These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33891972)

  • 1. The Heart-Brain Connection in Depression: Can it inform a personalised approach for repetitive transcranial magnetic stimulation (rTMS) treatment?
    Michael JA; Kaur M
    Neurosci Biobehav Rev; 2021 Aug; 127():136-143. PubMed ID: 33891972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5 Hz Repetitive transcranial magnetic stimulation for posttraumatic stress disorder comorbid with major depressive disorder.
    Carpenter LL; Conelea C; Tyrka AR; Welch ES; Greenberg BD; Price LH; Niedzwiecki M; Yip AG; Barnes J; Philip NS
    J Affect Disord; 2018 Aug; 235():414-420. PubMed ID: 29677606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial.
    Hadas I; Sun Y; Lioumis P; Zomorrodi R; Jones B; Voineskos D; Downar J; Fitzgerald PB; Blumberger DM; Daskalakis ZJ
    JAMA Netw Open; 2019 Jun; 2(6):e195578. PubMed ID: 31167023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control.
    Corlier J; Burnette E; Wilson AC; Lou JJ; Landeros A; Minzenberg MJ; Leuchter AF
    J Affect Disord; 2020 Mar; 265():272-277. PubMed ID: 32090751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Circular RNA DYM Related to Major Depressive Disorder and Rapid Antidepressant Effect Treated by Visual Cortical Repetitive Transcranial Magnetic Stimulation.
    Song R; Bai Y; Li X; Zhu J; Zhang H; Shi Y; Li K; Wang B; Zhang H; Yang Y; Zhang Z
    J Affect Disord; 2020 Sep; 274():486-493. PubMed ID: 32663980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive transcranial magnetic stimulation treatment of major depressive disorder and comorbid chronic pain: response rates and neurophysiologic biomarkers.
    Corlier J; Tadayonnejad R; Wilson AC; Lee JC; Marder KG; Ginder ND; Wilke SA; Levitt J; Krantz D; Leuchter AF
    Psychol Med; 2023 Feb; 53(3):823-832. PubMed ID: 34154683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: A systematic review and multiple-treatments meta-analysis.
    Chen JJ; Zhao LB; Liu YY; Fan SH; Xie P
    Behav Brain Res; 2017 Mar; 320():30-36. PubMed ID: 27876667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder: theoretical and practical considerations].
    Döme P; Faludi G; Eleméry M; Réthelyi J
    Psychiatr Hung; 2020; 35(2):146-174. PubMed ID: 32191220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil.
    Feifel D; Pappas K
    J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials.
    Razza LB; Moffa AH; Moreno ML; Carvalho AF; Padberg F; Fregni F; Brunoni AR
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():105-113. PubMed ID: 29111404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functioning as predictor and marker of response to repetitive transcranial magnetic stimulation in depressive disorders: A systematic review.
    Toffanin T; Folesani F; Ferrara M; Belvederi Murri M; Zerbinati L; Caruso R; Nanni MG; Koch G; Fadiga L; Palagini L; Perini G; Benatti B; Dell'Osso B; Grassi L
    Gen Hosp Psychiatry; 2022; 79():19-32. PubMed ID: 36240649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotherapy and psychopharmacology utilization following repetitive transcranial magnetic stimulation (rTMS) in patients with major depressive disorder.
    Needs P; Mote SD; Manocchia M; King JD; Szuba DD; Lustig SL; Shah VN
    Psychiatry Res; 2019 Aug; 278():51-55. PubMed ID: 31146141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and meta-analysis.
    Gellersen HM; Kedzior KK
    BMC Psychiatry; 2019 May; 19(1):139. PubMed ID: 31064328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segregation of salience network predicts treatment response of depression to repetitive transcranial magnetic stimulation.
    Fan J; Tso IF; Maixner DF; Abagis T; Hernandez-Garcia L; Taylor SF
    Neuroimage Clin; 2019; 22():101719. PubMed ID: 30776777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive Transcranial Magnetic Stimulation Combined with Antidepressants for the First Episode of Major Depressive Disorder.
    Maneeton B; Maneeton N; Woottiluk P; Likhitsathian S
    Curr Neuropharmacol; 2020; 18(9):852-860. PubMed ID: 32091338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis.
    Voigt J; Carpenter L; Leuchter A
    PLoS One; 2017; 12(10):e0186950. PubMed ID: 29073256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?
    Kobayashi B; Cook IA; Hunter AM; Minzenberg MJ; Krantz DE; Leuchter AF
    Int Rev Psychiatry; 2017 Apr; 29(2):98-114. PubMed ID: 28362541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.